Unknown NA INTERVENTIONAL 2-arm NCT04347330

Cardiovascular Risk Reduction in Atrial Fibrillation Trial (CRAFT)

Sponsor: Beijing Anzhen Hospital

Conditions Atrial Fibrillation Hypertension

Interventions Intensive BP Control Standard BP Control

Updated 11 times since 2020 Last updated: Dec 4, 2023 Started: Aug 31, 2020 Primary completion: Jun 30, 2024 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Atrial Fibrillation and Hypertension and is currently ongoing. Beijing Anzhen Hospital leads this study, which shows 11 recorded versions since 2020 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

11 versions recorded

Feb 2026 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Feb 2026 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jan 2024 — Jul 2024 [monthly]

Recruiting NA
Dec 2023 — Jan 2024 [monthly]

Recruiting NA

▶ Show 6 earlier versions

Sep 2023 — Dec 2023 [monthly]

Recruiting NA
Sep 2021 — Sep 2023 [monthly]

Recruiting NA
Jan 2021 — Sep 2021 [monthly]

Recruiting NA
Oct 2020 — Jan 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Aug 2020 — Oct 2020 [monthly]

Not Yet Recruiting NA
May 2020 — Aug 2020 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Anzhen Hospital
Fukuoka University
Heart Health Research Center
The George Institute for Global Health, Australia
The George Institute for Global Health, China

Data source: Beijing Anzhen Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China